Nitrogen-containing fused heterocyclic compounds and their use as beta amyloid production inhibitors

A compound represented by the formula [I]: or a pharmacologically acceptable salt or ester thereof, wherein Ring A represents a five-membered aromatic heterocyclic group or the like fused with a non-aromatic ring group, which may be substituted, Ring B represents a phenyl group or the like which may...

Full description

Saved in:
Bibliographic Details
Main Authors SHINMYO, DAISUKE, SATO, NOBUAKI, WATANABE, TORU, ITO, KOICHI, HASEGAWA, DAIJU, UEMURA, TOSHIYUKI, KITAZAWA, NORITAKA
Format Patent
LanguageEnglish
French
German
Published 17.07.2013
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:A compound represented by the formula [I]: or a pharmacologically acceptable salt or ester thereof, wherein Ring A represents a five-membered aromatic heterocyclic group or the like fused with a non-aromatic ring group, which may be substituted, Ring B represents a phenyl group or the like which may be substituted, X1 represents a single bond or the like, R1 and R2 each represent a C1-6 alkyl group or the like, m represents an integer of 0 to 3, and n represents an integer of 0 to 2, is effective as a therapeutic agent for a disease caused by A².
Bibliography:Application Number: EP20130162886